Wessex Neurology offers high quality, private neurology services for all general neurological conditions including headache, tremor, Parkinson’s disease, epilepsy, multiple sclerosis, sensory symptoms or weakness, dizziness, balance problems, neuropathy and other nerve problems, and motor neurone disease.

We also provide diagnosis and management of memory loss and dementia (including Alzheimer’s disease, Lewy Body disease, vascular dementia, frontotemporal dementia, atypical Parkinsonian syndromes and Huntington’s disease).

Following diagnosis, we work with many highly qualified local therapists and follow-up services to provide personalised ongoing care.

We can link to research studies where these are available in the region.

Professor Kipps is a Consultant Neurologist at Wessex Neurological Centre (Southampton) and Royal Hampshire County Hospital (Winchester) and Professor of Clinical Neurology and Dementia at University of Southampton.

Prof. Kipps qualified at University of New South Wales in 1993, and undertook post-graduate clinical training in Sydney, Australia. During his neurology training, he worked as a movement disorders fellow at Westmead Hospital and completed a diploma in Clinical Epidemiology at the University of Sydney.

In 2003 he moved to the UK to take up a training fellowship at the Radcliffe Infirmary in Oxford, before moving to Cambridge to undertake a research PhD in imaging, neuropsychology and dementia with Prof. John Hodges.

In 2007 he moved to the Wessex Neurological Centre in Southampton where he continues to have a wide range of general neurology interests, with particular expertise in dementia.

He is a clinical lead for the Mental Health, Dementia and Neurology Division in the Wessex Clinical Research Network (CRN), a co-lead for the Interdisciplinary Dementia and Ageing Centre (iDeAC), theme co-lead for the Data Health and Society Theme in the Southampton Biomedical Research Centre and Clinical Director for R&D at University Hospital Southampton.

He has an active research programme in dementia and long-term neurological conditions, and leads a range of interventional and observational trials.